Highlights Hua Medicine (Shanghai) Ltd.

Equities

2552

KYG4644K1022

Market Closed - Hong Kong S.E. Other stock markets 01:38:08 27/06/2024 pm IST			5-day change	1st Jan Change
1.48 ^HKD	-3.27%		-8.07%	-24.87%

28/03	Hua Medicine Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Hua Medicine Ltd. Appoints Yi Zhang as Executive Director with Effect from January 1, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hua Medicine Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03	CI
Hua Medicine Submits Investigational New Drug Application with the U.S. Food and Drug Administration for the 2Nd Generation Glucokinase Allosteric Activator	21/12	CI
Hua Medicine Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/23/24	CI
Hua Medicine Signs Distribution Agreement with Digital Healthcare Platform	11/23/11	MT
Hua Medicine Shrinks Loss in 2022 as Revenue Witnesses a Boost	29/23/29	MT
Hua Medicine Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	29/23/29	CI
Hua Medicine Unit Buys 100% Stake in Diabetes Drug Research Company	18/22/18	MT
China OKs Hua Medicine's New Drug Application for Type 2 Diabetes Treatment; Shares slipped 11%	10/22/10	MT
Hua Medicine Announces Approval of NDA of Huatangning, Innovative First-In-Class GKA Potential Inside Information	09/22/09	CI
Hua Medicine Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/22/25	CI
Hua Medicine Narrows Loss in 2021 as Expenses Fall	17/22/17	MT
Hua Medicine Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	16/22/16	CI
Hua Medicine Ltd. Announces Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2021	19/21/19	CI
Hua Medicine Shanghai : Grants One Million Share Options to Investors	07/21/07	MT
Hua Medicine Shanghai : China Accepts Application of Hua Medicine's Diabetes Drug; Shares Soar 14%	23/21/23	MT
Hua Medicine Ltd. Reports Consolidated Earnings Results for the Year Ended December 31, 2020	22/21/22	CI
Hua Medicine Shanghai : Trims 2020 Loss on Lower Expenses	19/21/19	MT
Hua Medicine Ltd. Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2020	19/21/19	CI
Hua Medicine Ltd. Resolves Not to Declare Any Final Dividend for the Year Ended December 31, 2020	19/21/19	CI
Hua Medicine Ltd. Updates on Its Clinical Trails	19/21/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Hua Medicine (Shanghai) Ltd.

Equities

2552

KYG4644K1022

Highlights

Filters